| Dr James Bennett, MD | |
|
1430 Tulane Ave, New Orleans, LA 70112-2632 | |
| (504) 988-2300 | |
| (504) 988-4200 |
| Full Name | Dr James Bennett |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery - Pediatric Orthopaedic Surgery |
| Location | 1430 Tulane Ave, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538259478 | NPI | - | NPPES |
| 1353361 | Medicaid | LA |
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Insurers are fleeing the market for children only health plans because of a new requirement that forces them to take on new policy holders, even if they are already sick.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the year and the fourth quarter ended December 31, 2009.
Intermedix Corporation, the leading provider of technology-based business services to emergency healthcare service providers, announced today the acquisition of EMSystems, LLC ("EMSystems"), a leading provider of web-based healthcare information technology solutions in the public health and emergency services markets.
The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.
› Verified 1 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245434224 PECOS PAC ID: 0446163760 Enrollment ID: O20040114000146 |
News Archive
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Insurers are fleeing the market for children only health plans because of a new requirement that forces them to take on new policy holders, even if they are already sick.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the year and the fourth quarter ended December 31, 2009.
Intermedix Corporation, the leading provider of technology-based business services to emergency healthcare service providers, announced today the acquisition of EMSystems, LLC ("EMSystems"), a leading provider of web-based healthcare information technology solutions in the public health and emergency services markets.
The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Bennett, MD 1430 Tulane Ave, Tw22, New Orleans, LA 70112-2632 Ph: (504) 988-2300 | Dr James Bennett, MD 1430 Tulane Ave, New Orleans, LA 70112-2632 Ph: (504) 988-2300 |
News Archive
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Insurers are fleeing the market for children only health plans because of a new requirement that forces them to take on new policy holders, even if they are already sick.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the year and the fourth quarter ended December 31, 2009.
Intermedix Corporation, the leading provider of technology-based business services to emergency healthcare service providers, announced today the acquisition of EMSystems, LLC ("EMSystems"), a leading provider of web-based healthcare information technology solutions in the public health and emergency services markets.
The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.
› Verified 1 days ago
Amit Kumar Sharma, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Henry Clay Ave, Ste 4103 Children's Hospital, New Orleans, LA 70118 Phone: 504-896-9569 | |
Dr. Joseph A. Gonzales Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Henry Clay Avenue, New Orleans, LA 70118 Phone: 504-896-9569 | |
Dr. Raoul Pedro Rodriguez, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2177 Fax: 504-988-4200 | |
Dr. Mark S Meyer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Timothy John Skalak, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-899-3496 Fax: 504-896-9849 | |
Leslie Elaine Sisco, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3970 Fax: 504-842-6784 | |
Dr. Charles R Billings, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2177 Fax: 504-988-4200 |